IMPORTANT: Even as postal services resume, mail delivery delays are expected. Sign up for secure website access and direct deposit.

Winter break: Our offices are closed December 25, 2024 - January 1, 2025. Regular hours resume January 2, 2025. Our member site and app are available 24/7.

Close
Skip to main content
Home Types of providers

Pharmacy

Providers

Pharmacy providers

Communications/Benefacts

Alberta Blue Cross® now offers online access to the most current up-to-date Pharmacy Benefacts and supplemental claiming information to assist with the submission of your direct bill drug claims.

Most commonly referenced

Limited restriction benefits

  • Benefact number 335

    Average criteria for Champix revised for Alberta Government sponsored programs

  • Benefact number 276

    Cyclobenzaprine 10 mg Tablets Restricted Benefit for Drug Programs Sponsored by Alberta Government

Archive

  • June 2024 - Benefact number 1182

    Product Identification Numbers (PINs) for Insulin Pump Therapy Program (IPTP)

  • June 2024 - Benefact number 1180

    COVID-19 Oral Antiviral PaxlovidTM—REMINDER

  • May 2024 - Benefact number 1179 - Drug Status

    Alberta Drug Benefit List (ADBL) interim update now available online

    Maximum Allowable Cost (MAC) pricing reminder for diclofenac under Alberta government sponsored drug programs

    Removal of temporary benefits from the ADBL

  • May 2024 - Benefact number 1176 - Drug Status

    Importation of United States-labelled Cholestyramine for Oral Suspension due to shortage

    Reminder for imported temporary benefit (US) Colesevelam 625 mg Tablet

  • May 2024 - Benefact number 1175

    Provider website reminders

  • May 2024 - Benefact number 1174

    Provider website enhancements and reminders

  • May 2024 - Benefact number 1173 - Drug Status

    Product supply shortages addressed for the Alberta Drug Benefit List (ADBL)

  • May 2024 - Benefact number 1172

    Reminder: Paxlovid—no cost federal supply is still available to order until May 24, 2024

  • May 2024 - Benefact number 1171

    Ustekinumab added to the Alberta Biosimilar Initiative

  • April 2024 - Benefact number 1170 - Drug Status

    Alberta Drug Benefit List (ADBL) interim update now available online

  • April 2024 - Benefact number 1169 - Drug Status

    Importation of United States-labelled colesevelam hydrochloride due to shortage of Canadian-labelled colesevelam hydrochloride

  • April 2024 - Benefact number 1168

    COVID-19 immunization program update

  • April 2024 - Benefact number 1166 - Drug Status

    April 1, 2024 Full Updates for the Alberta Drug Benefit List (ADBL), Alberta Human Services Drug Benefit Supplement (HSDBS) and Palliative Coverage Drug Benefit Supplement (PCDBS)

  • March 2024 - Benefact number 1165 - Drug Status

    Reminder: adjustment to assessment for administration of COVID-19 vaccine and Product supply shortages addressed for Alberta Drug Benefit List (ADBL)

  • March 2024 - Benefact number 1164

    Alberta Vaccine Inventory (AVI) and provincially funded vaccine updates

  • March 2024 - Benefact number 1163

    Influenza Immunication 2024 to 2024 – Pharmacy End of Season

  • March 2024 - Benefact number 1162

    Important update: Paxlovid federal supply ending expiry dates, adjusting packs and commercial supply

  • March 2024 - Benefact number 1161 – Drug Status

    Temporary Benefit added to the Alberta Drug Benefit List (ADBL)

    Product supply shortages addressed for ADBL

  • February 2024 - Benefact number 1159 – Drug Status

    Alberta Drug Benefit List (ADBL) interim update now available online

    Temporary benefit added to the ADBL

    Removal of temporary benefits from the ADBL

    Product supply shortages addressed for ADBL

  • February 2024 - Benefact number 1157

    Ozempic (semaglutide) eligibility for Government of Northwest Territories (GNWT) health benefit programs

  • January 2024 - Benefact number 1155 - Drug Status

    Alberta Drug Benefit List (ADBL) interim update now available online

    Removal of temporary benefit from the ADBL

    Product supply shortages addressed for ADBL

  • January 2024 - Benefact number 1154 - Drug Status

    Temporary benefit added to the Alberta Drug Benefit List (ADBL)

    Removal of temporary benefit from the ADBL

  • January 2024 - Benefact number 1153 - Drug Status

    Temporary benefit added to the Alberta Drug Benefit List (ADBL)

  • January 2024 - Benefact number 1152 - Drug Status

    Temporary benefits added to the Alberta Drug Benefit List (ADBL)

  • Benefact number 1116 - Alberta Influenza Immunization Program 2023/2024

  • Benefact number 1013 - Addition of Continuous Glucose Monitors to Alberta government-sponsored plans

    Submission of glucose monitoring systems for Alberta Blue Cross® employer-sponsored group and individual health plans

  • December 2023 - Alberta Blue Cross® and Workers’ Compensation Board –Alberta (WCB-Alberta) continue to expand access to direct billing of prescription drugs for worker claims

  • December 2023 - Narcotic Transition Services (NTS)

  • December 2023 - Benefact number 1148 - Drug Status

    Importation of United Kingdom-labelled Glyceryl Trinitrate Nitroglycerin) 0.4 mg/dose Sublingual Metered Dose Spray due to shortage of Canadian-authorized nitroglycerin sublingual sprays

    Temporary benefit added to the Alberta Drug Benefit List(ADBL)

  • November 2023 - Benefact number 1145 - Drug Status

    Alberta Drug Benefit List (ADBL) interim update now available online

    Temporary benefit added to the Alberta Drug Benefit List (ADBL)

    Removal of temporary benefits from the Alberta Drug Benefit List (ADBL)

    Product supply shortage addressed for Alberta Drug Benefit List (ADBL)

  • November 2023 - Eligible Insulin Pumps and Pump Supplies are available as limited-use benefits for Government of Northwest Territories (GNWT) health benefit programs

  • October 2023 - Assessment for Ensuring Continuity of Care in the Event of a Declaration of a State of Emergency or Declaration of a State of Local Emergency

  • October 2023 - Benefact number 1139 - Drug Status

    Importation of United States-labelled Vigabatrin 500 mg Oral Powder Packet due to shortage of vigabatrin

  • October 2023 - Benefact number 1138 - Drug Status

    Alberta Drug Benefit List (ADBL) interim update now available online

    Temporary benefits added to the ADBL

    Removal of temporary benefit from the ADBL

    Product supply shortages addressed for ADBL

  • October 2023 - Alberta Health Influenza Antiviral Drug Policy as applied to vulnerable populations living in congregate living settings

  • October 2023 - Benefact number 1136 - Drug Status

    Importation of United States-labelled Prazosin Hydrochloride Capsules due to shortage of Prazosin Hydrochloride Tablets

  • September 2023 - Benefact number 1129 - Drug Status

    Alberta Drug Benefit List (ADBL) Interim Update now available online

    Removal of temporary benefits from the Alberta Drug Benefit List (ADBL)

    Product supply shortages addressed for ADBL

    Temporary benefit added to the Alberta Drug Benefit List (ADBL)

  • September 2023 - Benefact number 1128 - Drug Status

    Product supply shortages addressed for Alberta Drug Benefit List (ADBL)

  • July 2023 - Northwest Territories Wildfire Emergency

  • July 2023 - Benefact number 1122 - Drug Status

    Alberta Drug Benefit List (ADBL) Interim Update now available online Temporary benefits added to the ADBL

    Removal of temporary benefit from the ADBL

    Product supply shortage addressed for ADBL

  • July 2023 - Benefact number 1120 - Drug Status

    Product supply shortages addressed for Alberta Drug Benefit List (ADBL)

    Temporary benefit added to the Alberta Drug Benefit List (ADBL)

    Removal of temporary benefits from the Alberta Human Services Drug Benefit Supplement (HSDBS)

  • July 2023 - Enhanced website functionality accommodates product status and pricing inquiries

  • June 2023 - Benefact number 1117 - Drug Status

    Alberta Drug Benefit List (ADBL) Interim Update now available online

    Temporary benefit added to the Alberta Drug Benefit List (ADBL)

  • June 2023 - Benefact number 1115 - Drug Status

    Temporary benefit added to the Alberta Drug Benefit List (ADBL)

    Removal of Temporary Benefits from the ADBL

    Product supply shortages addressed for Alberta Drug Benefit List (ADBL)

  • June 2023 - Enhancements to Medical Supplies and Equipment claiming for the Government of Northwest Territories (GNWT) Extended Health Benefit programs

  • June 2023 - Alberta Blue Cross® and Workers’ Compensation Board – Alberta (WCB-Alberta) continue to expand access to direct billing of prescription drugs for worker claims

  • June 2023 - Updates to eligibility for flash and continuous glucose monitor (CGM) systems effective June 9, 2023, for Government of the Northwest Territories (GNWT) Seniors (Group 60), Specified Disease Conditions (Group 21992) and Métis Health Benefit (Group 19866) programs

  • June 2023 - Benefact number 1110 - Drug Status

    Product supply shortages addressed for Alberta Drug Benefit List (ADBL)

    Temporary Benefit added to the ADBL

  • May 2023 - Benefact number 1109 - Drug Status

    Alberta Drug Benefit List (ADBL) Interim Update now available online

    Product supply shortages addressed for Alberta Drug Benefit List (ADBL)

  • May 2023 - Submitting claims for prescriptions from Physicians Assistants

  • May 2023 - Alberta Wildfire Emergency

  • May 2023 - Benefact number 1106 - Drug Status

    Product supply shortages addressed for Alberta Drug Benefit List (ADBL)

    Removal of Temporary Benefits from the Alberta Drug Benefit List (ADBL)

    Temporary Benefits added to the Alberta Drug Benefit List (ADBL)

  • May 2023 - Declaration of a State of Local Emergency for Parkland and Yellowhead Counties, Alberta residents

  • April 2023 - Benefact number 1103 - Drug Status

    Alberta Drug Benefit List (ADBL) Interim Update now available online

    Product supply shortages addressed for Alberta Drug Benefit List (ADBL)

    Temporary Benefits added to the Alberta Drug Benefit List (ADBL)

    Removal of temporary benefit from the Alberta Drug Benef it List (ADBL)

  • April 2023 - Update to Pharmacy Teams on Importation Liquid Pediatric Ibuprofen with Child-Resistant Packaging

  • April 2023 - Benefact number 1101 - Drug Status

    Temporary Benefits added to the Alberta Drug Benefit List (ADBL)

    Removal of Temporary Benefit from the Alberta Drug Benefit List (ADBL)

    Product supply shortages addressed for Alberta Drug Benefit List (ADBL)

  • April 2023 - Influenza immunization 2022 to 2023—pharmacy end of season

  • March 2023 - Benefact number 1099 - Drug Status

    April 1, 2023, Full Updates for the Alberta Drug Benefit List (ADBL), Alberta

    Human Services Drug Benefit Supplement (HSDBS) and Palliative Coverage Drug

    Benefit Supplement (PCDBS)

  • March 2023 - Benefact number 1097 - Drug Status

    Reminder: ONLY SELECT Workers’ Compensation Board – Alberta (Group 23737, Section A) worker claims are eligible for direct bill through Alberta Blue Cross®

    Updates to the Alberta Blue Cross® Critical Supply List

    Temporary Benefit added to the Alberta Drug Benefit List (ADBL)

    Product supply shortages addressed for Alberta Drug Benefit List (ADBL)

  • March 2023 - Update to Pharmacy Teams on Importation Liquid Pediatric Acetaminophen with Child- Resistant Packaging

  • March 2023 - Benefact number 1093 - Drug Status

    Product supply shortages addressed for Alberta Drug Benefit List (ADBL)

    Removal of temporary benefits from the Alberta Drug Benefit List (ADBL)

  • February 2023 - Benefact number 1092 - Drug Status

    Alberta Drug Benefit List (ADBL) Interim Update now available online

    Removal of temporary benefits from the Alberta Drug Benefit List (ADBL)

    Temporary benefit added to the Alberta Drug Benefit List (ADBL)

    Product supply shortages addressed for Alberta Drug Benefit List (ADBL)

  • February 2023 - Enhancing the pharmacy provider website provides oral compound authorizations in real-time to better meet your needs

  • February 2023 - Benefact number 1090 - Drug Status

    Drug product shortage information

    Assessing a drug shortage

    Drug shortage resolutions

  • February 2023 - Updates to the Insulin Pump Therapy Program (IPTP) coverage for insulin pumps and supplies

  • February 2023 - Enhancement to the claiming process for eligible flash and continuous glucose monitoring systems for Government of Northwest Territories (GNWT) health benefit programs

  • February 2023 - Benefact number 1084 - Drug Status

    Quarterly update regarding the Authorized Adjustment

    Temporary Benefit added to the Alberta Drug Benefit List (ADBL)

    Removal of Temporary Benefits from the ADBL

    Product supply shortage addressed for the ADBL

  • January 2023 - Workplace naloxone: information for pharmacy teams

  • January 2023 - Benefact number 1082 - Drug Status

    Alberta Drug Benefit List (ADBL) Interim Update now available online

    Temporary benefit added to the Alberta Drug Benefit List (ADBL)

    Removal of Temporary Benefit from the Alberta Drug Benefit List (ADBL)

    Product supply shortage addressed for Alberta Drug Benefit List (ADBL)

  • January 2023 - Benefact number 1081 - Drug Status

    Importation of Cyprus-labelled Moxilen (Amoxicillin) 250 mg/5mL suspension due to shortage of antibiotic oral suspensions in Canada

  • January 2023 - Benefact number 1080 - Drug Status

    Temporary benefits added to the Alberta Drug Benefit List (ADBL)

    Removal of temporary benefit from the Alberta Drug Benefit List (ADBL)

    Product supply shortage addressed for Alberta Drug Benefit List (ADBL)

  • December 2022 - Additional insulin pumps and associated supplies added to the Insulin Pump Therapy Program (IPTP).

  • December 2022 - Benefact number 1078 - Drug Status

    Removal of temporary benefit from the Alberta Drug Benefit List (ADBL)

    Temporary benefit added to the Alberta Drug Benefit List (ADBL)

    Product supply shortage addressed for Alberta Drug Benefit List (ADBL)

  • December 2022 - Benefact number 1076 - Drug Status

    Importation of USA – Children’s TYLENOL Oral Suspension due to shortage of pediatric analgesics

    Additional temporary benefit added to the Alberta Drug Benefit List (ADBL) due to amoxicillin oral suspension shortage

    Temporary benefit added to the ADBL

  • November 2022 - Changes to ASEBP drug management programs

  • November 2022 - Benefact number 1074 - Drug Status

    Alberta Drug Benefit List (ADBL) interim update now available online

    Temporary benefit added to the Alberta Drug Benefit List (ADBL)

    Product supply shortage addressed for Alberta Drug Benefit List (ADBL)

  • November 2022 - Benefact number 1073 - Drug Status

    Temporary benefits added to the Alberta Drug Benefit List (ADBL)

  • November 2022 - Benefact number 1072 - Drug Status

    Coverage of Pediatric Acetaminophen and Ibuprofen and Temporary Benefits

  • November 2022 - Benefact number 1070 - Drug Status

    Temporary benefits added to the Alberta Drug Benefit List (ADBL)

    Quarterly update regarding the Authorized Adjustment

  • October 2022 - Benefact number 1069 - Drug Status

    Temporary benefits added to the Alberta Drug Benefit List (ADBL)

    Removal of temporary benefit from the ADBL

    Product supply shortage addressed for ADBL

  • October 2022 - Benefact number 1068 - Drug Status

    Alberta Drug Benefit List (ADBL) Interim Update now available online

  • October 2022 - Benefact number 1066 - Drug Status

    Temporary benefits added to the Alberta Drug Benefit List (ADBL)

  • October 2022 - Lowest cost equivalent drug adjudication

  • October 2022 - Alberta Influenza Immunization Program 2022/2023 – updating inventory on the pharmacy provider website

  • October 2022 - Changes to the claiming process for our national members

  • October 2022 - Alberta Blue Cross® reminds pharmacies of the ability to obtain real-time authorizations for more than 100-day medication supplies

  • September 2022 - Alberta Health Services introduces the Alberta Lung Cancer Screening Pilot as part of AlbertaQuits (Group number 23699, Section D)

  • September 2022 - Benefact number 1061 - Drug Status

    National Day for Truth and Reconciliation—September 30, 2022

    Alberta Drug Benefit List (ADBL) interim update now available online

    Temporary benefit added to the Alberta Drug Benefit List (ADBL)

    Product supply shortage addressed for Alberta Drug Benefit List (ADBL)

  • September 2022 - Alberta Health Influenza Antiviral Drug Policy as applied to vulnerable populations living in congregate living settings

  • September 2022 - Benefact number 1059 - Drug Status

    Temporary benefit added to the Palliative Coverage Drug Benefit Supplement (PCDBS)

    Removal of temporary benefits from the Alberta Drug Benefit List (ADBL)

  • September 2022 - Benefact number 1057 - Drug Status

    Product supply shortage addressed for the Alberta Drug Benefit List (ADBL)

  • September 2022 - Alberta Public Health Activities Program (APHAP) Alberta Influenza Immunization Program 2022/2023

    Key updates for this year—COVID-19 vaccine considerations, Alberta Vaccine Inventory Reporting Process, Alberta Vaccine Booking System

  • August 2022 - Benefact number 1053 - Drug Status

    Alberta Drug Benefit List (ADBL) Interim Update now available online

    Product supply shortage addressed for the Alberta Drug Benefit List (ADBL)

  • August 2022 - Benefact number 1052 - Drug Status

    Reminder of Maximum Allowable Cost (MAC) pricing reinstatement to combination Angiotension-Converting Enzyme (ACE) inhibitor groupings

    Product supply shortage addressed for Alberta Drug Benefit List (ADBL)

    Temporary benefit added to the Alberta Drug Benefit List (ADBL)

  • August 2022 - Benefact number 1051 - Drug Status

    Temporary benefit added to the Alberta Drug Benefit List (ADBL)

    Temporary Benefit added to the Alberta Human Services Drug Benefit Supplement (HSDBS)

  • August 2022 - Update to website manual drug claim submissions

  • August 2022 - Benefact number 1047 - Drug Status

    Product supply shortage addressed for the Alberta Drug Benefit List (ADBL)

  • August 2022 - Claim submission tips for 1976 drug authorization claims

  • August 2022 - Benefact number 1044 - Drug Status

    Importation of UK-labelled Alfamino Infant Formula Powder and US-labelled Gerber Good Start Extensive HA Infant Formula Powder due to shortages of specialized infant formula

  • July 2022 - Benefact number 1043 - Drug Status

    Alberta Drug Benefit List (ADBL) Interim Update now available online

    Temporary benefit added to the Alberta Drug Benefit List (ADBL)

    Removal of temporary benefit from the Alberta Human Services Drug Benefit Supplement (HSDBS)

    Product supply shortage addressed for Alberta Drug Benefit List (ADBL)

  • July 2022 - Benefact number 1042 - Drug Status

    Removal of temporary benefit from the Alberta Drug Benefit List (ADBL)

    Temporary benefit added to the Alberta Drug Benefit List (ADBL)

  • July 2022 - Enhanced website functionality accommodates manual drug claim submissions

  • July 2022 - Benefact number 1040 - Drug Status

    Importation of USA - Cortef 10 mg Tablet due to shortage

  • June 2022 - Benefact number 1038 - Drug Status

    Alberta Drug Benefit List (ADBL) Interim Update now available online

    Insulin Pump Therapy Program termination on hold

    Product supply shortages addressed for the Alberta Drug Benefit List (ADBL)

    Temporary benefit added to the Alberta Drug Benefit List (ADBL)

    Temporary benefit added to the Alberta Human Services Drug Benefit Supplement (HSDBS)

    Removal of temporary benefits from the Alberta Drug Benefit List (ADBL)

  • June 2022 - Benefact number 1037 - Drug Status

    Update on shortage of specialized infant formula Importation of United States-labelled Nutramigen A+ Concentrate Infant Formula due to shortage of specialized infant formula

  • June 2022 - Declaration of a state of local emergency for Calgary and Municipal District of Bighorn, Alberta residents

  • June 2022 - Benefact number 1035 - Drug Status

    Temporary benefits added to the Alberta Drug Benefit List (ADBL)

    Product supply shortages addressed for Alberta Drug Benefit List (ADBL)

    Removal of a temporary benefit from the Alberta Drug Benefit List (ADBL)

  • June 2022 - Benefact number 1034 - Drug Status

    Importation of United States-labelled Nutramigen A+ Concentrate Infant Formula due to shortage of specialized infant formula

  • May 2022 - Benefact number 1033 - Drug Status

    Alberta Drug Benefit List (ADBL) Interim Update now available online

  • May 2022 - Enhancements to insulin pump supply claiming process for Government of Northwest Territories (GNWT) health benefit programs

  • Nay 2022 - Benefact number 1031 - Drug Status

    Removal of temporary benefit from the Alberta Drug Benefit List (ADBL)

    Temporary benefit added to the Alberta Human Services Drug Benefit Supplement (HSDBS)

  • May 2022 - Ukrainian Evacuee Temporary Health Benefits Program

  • May 2022 - Benefact number 1029 - Drug Status

    Product supply shortage addressed for Alberta Drug Benefit List (ADBL)

  • May 2022 - Insulin Pump Therapy Program changes

  • April 2022 - Benefact number 1026 - Drug Status

    Removal of temporary benefit from the Alberta Drug Benefit List (ADBL)

    Temporary benefit added to the Alberta Drug Benefit List (ADBL)

  • April 2022 - Benefact number 1024 - Drug Status

    Alberta Drug Benefit List (ADBL) Interim Update now available online

    Pan-Canadian Select Molecule Price Initiative for generic drugs

  • April 2022 - Opioid Agonist Therapy (OAT) Gap Coverage Program

    Reminder: Humira delisted on government-sponsored drug plans

  • April 2022 - Tramadol compound PIN update

    Paxlovid™ dispensing update

  • March 2021 - Benefact number 1021 - Drug Status

    April 1, 2022 Full Updates for the Alberta Drug Benefit List (ADBL), Alberta Human Services Drug Benefit Supplement (HSDBS) and Palliative Coverage Drug Benefit Supplement (PCDBS)

  • March 2022 - Ukrainian Evacuee Temporary Health Benefits Program

  • March 2022 - Alberta Public Health Activities Program (APHAP) influenza immunization end of 2021 to 2022 season

  • March 2022 - Alberta Blue Cross® individual and employer-sponsored group plans—step therapy dosing controls

  • February 2022 - Benefact number 1016 - Drug Status

    Alberta Drug Benefit List (ADBL) Interim Update now available online

    pan-Canadian Select Molecule Price Initiative for Generic Drugs

    Product supply shortage addressed for the Alberta Drug Benefit List (ADBL)

    Temporary benefit added to the Alberta Drug Benefit List (ADBL)

  • February 2022 - Addition of Continuous Glucose Monitors to Alberta government-sponsored plans

    Submission of glucose monitoring systems for Alberta Blue Cross® employer-sponsored group and individual health plans

  • February 2022 - Palliative care support—updated claiming process for pre-filled syringes

  • January 2022 - BIOSIMILARS INITIATIVE UPDATE – Delisting of Humalog, reminders of NovoRapid and Humira

    Alberta Drug Benefit List (ADBL) interim update now available online

    Temporary benefit added to the ADBL

  • December 2021 - Benefact number 1004 - Drug Status

    Temporary benefit added to the Alberta Drug Benefit List (ADBL)

  • December 2021 - The Government of the Northwest Territories announces Biosimilars Initiative

  • December 2021 - Alberta Blue Cross® group plans–enhanced step therapy management to apply dosing controls

  • December 2021 - Benefact number 999 - Drug Status

    Product supply shortage addressed for Alberta Drug Benefit List (ADBL)

    Temporary benefit added to the Alberta Drug Benefit List (ADBL)

    Removal of temporary benefit from the Palliative Coverage Drug Benefit Supplement (PCDBS)

  • December 2021 - Blood glucose test strip claims for Alberta Blue Cross® employer-sponsored group and personal health plans and Alberta government-sponsored programs

  • December 2021 - Update – PINs for blood glucose test strip claims for Alberta Blue Cross® employer-sponsored group and personal health plans

  • November 2021 - Benefact number 995 - Drug Status

    Product supply shortages addressed for Alberta Drug Benefit List (ADBL)

    Temporary benefit added to the Alberta Drug Benefit List (ADBL)

    Removal of temporary benefit from the Alberta Drug Benefit List (ADBL)

  • November 2021 - Verify you are using a valid Alberta prescriber identification number and reference code at time of claim

  • November 2021 - Sublocade added to Opioid Agonist Therapy (OAT) Gap Coverage Program

  • November 2021 - Benefact number 991 - Drug Status

    Product Supply Shortages Addressed for Alberta Drug Benefit List (ADBL)

  • October 2021 - Benefact number 990 - Drug Status

    Alberta Drug Benefit List (ADBL) Interim Update now available online

  • October 2021 - Extension of special authorizations for government-sponsored plans

  • October 2021 - Influenza immunization program updates for pharmacy

  • October 2021 - Alberta Health Influenza Antiviral Drug Policy as applied to Vulnerable Populations Living in Congregate Living Settings

  • October 2021 - Benefact number 986 - Drug Status

    Product supply shortages addressed for Alberta Drug Benefit List (ADBL)

  • October 2021 - Alberta vaccine records

    Vaccine administration claims

    Unique Lifetime Identifier (ULI) versus PHN

  • September 2021 - Benefact number 983 - Drug Status

    Trurapi added to the Alberta Biosimilar Initiative

  • September 2021 - A Reference guide for administering and claiming influenza vaccines

  • September 2021 - Benefact number 982 - Drug Status

    Alberta Drug Benefit List (ADBL) Interim Update for October 1, 2021

    Product added to Opioid Agonist Therapy (OAT) Gap Coverage Program

  • September 2021 - Benefact number 981 - Drug Status

    Product added to Opioid Agonist Therapy (OAT) Gap Coverage Program

    Product supply shortages addressed for ADBL

  • September 2021 - Alberta Influenza Immunization Program 2021-22

  • September 2021 - Alberta Health Insulin Pump Therapy Program— claiming for blood glucose test strips

  • August 2021 - Benefact number 975 - Drug Status

    Alberta Drug Benefit List (ADBL) Interim Update now available

  • August 2021 - Changes to coverage for diabetes supplies for Alberta Government-sponsored programs

  • August 2021 - Benefact number 972 - Drug Status

    Temporary benefit added to the Alberta Drug Benefit List (ADBL)

    Importation of USA-Depo-Provera 150 mg/ml Injection due to Shortage

  • July 2021 - Admelog added to the Alberta Biosimilar Initiative

  • July 2021 - Changes to coverage for diabetes supplies for Alberta Government-sponsored programs

  • July 2021 - Benefact number 969 - Drug Status

    Alberta Drug Benefit List (ADBL) Interim Update now available online

    Product supply shortages addressed for ADBL

    Removal of temporary benefits from the ADBL

  • July 2021 - Additional information regarding enhancements to Specified

    Disease Conditions, Seniors and Métis Health Benefits Programs

  • June 2021 - Enoxaparin added to the Alberta Biosimilar Initiative

    Pneumovax-23 change from vials to pre-filled syringes

  • June 2021 - Benefact number 965 - Drug Status

    Alberta Drug Benefit List (ADBL) Interim Update now available online

    Product supply shortages addressed for ADBL

    Removal of temporary benefits from the ADBL

  • June 2021 - Enhancements to Specified Disease Conditions, Seniors and Metis Health Benefits Programs

  • June 2021 - Benefact number 963 - Drug Status

    Product supply shortages addressed for Alberta Drug Benefit List (ADBL)

  • May 2021 - Palliative care support expanded—pre-filled syringes

    Quarterly update regarding the Authorized Adjustment

  • May 2021 - Benefact number 961 - Drug Status

    Alberta Drug Benefit List (ADBL) interim update now available online

    Product supply shortages addressed for ADBL

    Removal of imported temporary benefits from ADBL

  • May 2021 - Benefact number 959 - Drug Status

    Product supply shortages addressed for Alberta Drug Benefit List (ADBL)

    Removal of temporary benefit from the ADBL

    Temporary benefit added to the ADBL

  • May 2021 - Opioid Agonist Therapy (OAT) Gap Coverage Program and Extension

  • April 2021 - Benefact number 956 - Drug Status

    Adalimumab added to the Alberta Biosimilar Initiative

    Product added to Opioid Agonist Therapy (OAT) Gap

  • April 2021 - Benefact number 955 - Drug Status

    Alberta Drug Benefit List (ADBL) interim update now available online

    Temporary benefit added to the ADBL

    Product supply shortages addressed for ADBL

  • April 2021 - Benefact number 952 - Drug Status

    Product supply shortages addressed for Alberta Drug Benefit List (ADBL)

    Temporary benefit added to the ADBL

    Temporary benefit added to the Alberta Human Services Drug Benefit Supplement (HSBDS)

  • March 2021 - Benefact number 950 - Drug Status

    April 1, 2021 Full Updates for the Alberta Drug Benefit List (ADBL),Alberta Human Services Drug Benefit Supplement (HSDBS) and Palliative Coverage Drug Benefit Supplement (PCDBS)

  • March 2021 - End date for 2020/2021 Alberta Public Health Activities Program (APHAP) Influenza Immunization Season

  • March 2021 - Benefact number 944 - Drug Status

    Product supply shortages addressed for Alberta Drug Benefit List (ADBL)

    Removal of temporary benefit from the Alberta Drug Benefit List (ADBL)

  • February 2021 - Reminder: ONLY Alberta Retired Teachers’ Association (ARTA) “A” and “Q” sections from group 19930 move to Green Shield Canada

    Additional products added to the Alberta Public Health Activities Program (APHAP)

  • February 2021 - Benefact number 935 - Drug Status

    Alberta Drug Benefit List (ADBL) Interim Update now available online

  • February 2021 - Manual Drug Claim Form Enhancements

  • February 2021 - Reminder: Lantus delisted on government-sponsored drug plans

    Quarterly update regarding the Authorized Adjustment

  • February 2021 - Benefact number 931 - Drug Status

    Product supply shortages addressed for Alberta Drug Benefit List (ADBL)

    Temporary benefit added to the Alberta Drug BenefitList (ADBL)

  • January 2021 - Enhanced validation of valid prescriber identification numbers for claims adjudication

  • January 2021 - Benefact number 929 - Drug Status

    Alberta Drug Benefit List (ADBL) Interim Update now available online

  • January 2021 - Benefact number 928 - Drug Status

    Alberta Drug Benefit List (ADBL) update now available online

    Temporary change to Step Therapy for Direct-Acting Oral Anticoagulants (DOACs)

  • January 2021 - Alberta Biosimilars Initiative update

  • Janurary 2021 - Benefact number 926 - Drug Status

    Alberta Retired Teachers’ Association (ARTA), Group 19930 “A” Sections Only

    Removal of Temporary Benefit from the Alberta Drug Benefit List (ADBL)

    Product supply shortages addressed for Alberta Drug Benefit List (ADBL)

  • December 2020 - Introduction of Nutritional Product, Package Size, and UPC Listing now available under the Pharmacy Providers Resources page.

  • December 2020 - Step therapy for select narcotic drug products effective January 1, 2021, for Alberta Blue Cross® individual and employer-sponsored group plans.

  • December 2020 - Retroactive claims adjustments for Assessment for the Administration of a Publicly Funded Vaccine Fee.

  • December 2020 - Protection of Students with Life-threatening Allergies Act (PSLTA)—epinephrine auto-injector device supply for 2021.

  • October 2020 - Alberta’s Biosimilars Initiative update

    Temporary benefits added to the Alberta Drug Benefit List (ADBL)

  • October 2020 - Métis Nation of Alberta nicotine replacement therapy program (group number 23713 section A)

  • October 2020 - Increase to Assessment for the Administration of a Publicly Funded Vaccine fee

    Retroactive claims adjustment

  • October 2020 - Quantity authorizations for Alberta Health programs reinstated

  • September 2020 - Enhanced website provides topical compound authorizations in real time

  • September 2020 - Alberta Public Health Activities Program (APHAP) Influenza Immunization Program 2020/2021

  • July 2020 - Changes to the calculation of the co-payment for government-sponsored plans

    (Group 1 and 66) for products on the Critical Supply Product List

  • July 2020 - Extension of special authorizations for government-sponsored plans

    Temporary Benefit added to the Alberta Drug Benefit List (ADBL)

  • June 2020 - Influenza planning for the 2020/2021 season

  • June 2020 - Alberta Biosimilars Initiative Update

    Year-end update on the Holdback Policy

    Removal of temporary benefit from Alberta Human Services Drug Benefit

    Supplement (HSDBS)

  • June 2020 - Alberta Biosimilars Initiative Updates

  • June 2020 - Update on measures to prevent drug product shortages

    Information about products in a critical supply situation

    Quantity authorization

  • June 2020 - Alberta Biosimilars Initiative Updates

  • May 2020 - Importation of UK-Labelled Teva-Salamol CFC-Free (Salbutamol Sulfate) Inhaler due to Shortage

    Temporary change to Step Therapy for Direct-Acting Oral Anticoagulants (DOACs) on the Alberta Drug Benefit List (ADBL) effective May 15, 2020 for government-sponsored programs

  • April 2020 - Government coverage options for those impacted by COVID-19

  • April 2020 - Alberta Biosimilar Initiative – update to switching timelines in response to COVID-19

    Temporary access to Humira for Crohn’s Disease due to COVID-19

  • April 2020 -Temporary benefit added to the Alberta Drug Benefit List (ADBL)

    Temporary changes to coverage for Nicotine Products under the Alberta Human Services Drug Benefit Supplement

    Changes to the Government of Alberta’s Palliative Coverage Program

  • April 2020 - Enhanced access to Opioid Agonist Therapy (OAT)

  • April 2020 - Manual Drug Claim forms—enhancement of submission process

  • March 2020 - Alberta Public Health Activities Program (APHAP) Influenza Immunization end of 2019/2020 season

  • March 2020 - Updates regarding COVID-19 Pandemic

  • March 2020 - Updated Ministerial Order now available & Third quarter update on the Holdback policy

  • February 2020 - Alberta Health’s Coverage for Seniors program—income-based deductibles to be introduced in 2020

  • February 2020 - Reminder #2—Eligibility changes take effect March 1, 2020 to Alberta Health’s Coverage for Seniors Program.

  • February 2020 - Payment date change for AISH and Income Support

  • February 2020 - Reminder Eligibility changes to Coverage for Seniors Program

  • January 2020 - Alberta Biosimilar Initiative—patient support letter and resources

  • January 2020 - Alberta Health’s Coverage for Seniors Program—eligibility changes effective March 1, 2020

  • December 2019 - Calgary Catholic School District Group 14200-Drug Benefit Plan enhancements effective January 1, 2020

  • December 2019 - Have you received and returned your First Amending Agreement?

  • December 2019 - Pharmacies supporting local schools for the Protection of Students with Life-threatening Allergies Act

  • December 2019 - Alberta Health announces an important change to coverage for biologic products under Alberta government sponsored programs

  • December 2019 - Important reminder: Alberta Health’s change to coverage for select angiotensin-converting enzyme inhibitors (ACEIs), HMG-COA reductase inhibitors (statins) and calcium-channel blocking agents (CCBs) under Alberta government sponsored programs

  • December 2019 - Coverage criteria updates for select benefits of Government of Northwest Territories (GNWT) health benefit programs

  • December 2019 - Important reminder: Alberta Health’s change to coverage for select angiotensin-converting enzyme inhibitors (ACEIs), HMG-COA reductase inhibitors (statins) and calcium-channel blocking agents (CCBs) under Alberta government sponsored programs

  • November 2019 - Alberta Health announces an important change to coverage for select angiotensin-converting enzyme inhibitors (ACEIs), HMG-COA reductase inhibitors (statins) and calcium-channel blocking agents (CCBs) under Alberta government sponsored programs

  • October 2019 - Alberta Public Health Activities Program (APHAP) Influenza Immunization Program 2019/2020

  • July 2019 - First quarter update on the Holdback Policy

  • July 2019 - Nazia Pharmacy termination notice

  • May 2019 - Ensuring Continuity of Care for Residents displaced by the Northwest Alberta wildfire

  • March 2019 - OHIP+Program Changes

  • March 2019 - Changes to the payment summary reconciliation reports

  • March 2019 - Pharmacy funding Framework

  • February 2019 - Coverage criteria updates for select benefits of Government of Northwest Territories (GNWT) health benefit programs

  • January 2019 - Update to the Insulin Pump Therapy (IPT) Program

  • December 2018 - Alberta Blue Cross® Pharmaceutical Services Provider Agreement Compliance Verification Review process

  • November 2018 - Pneumococcal Polysaccharide 23-Valent Vaccine (Pneumo-P 23) added to the list of provincially funded vaccines for pharmacists

  • November 2018 - Diphtheria-Tetanus-Acellular Pertussis Combined Vaccine (dTap) added to the list of provincially-funded vaccines for pharmacists

  • October 2018 - Influenza Antiviral Drug Policy - Alberta Public Health Activities Program (APHAP)

  • September 2018 - Alberta Public Health Activities Program (APHAP) Influenza Immunization Program 2018/2019

  • August 2018 - Blood Glucose Test Strip Limit for employer sponsored coverage

  • July 2018 - Update to greater than 100 days’ medication supply for the clients of the Government of Northwest Territories (GNWT)

  • May 2018 - Direct bill batch claim processing: software updates for Frequent Dispensing Policy Special Services Codes

  • May 2018 - Alberta Blue Cross® Pharmaceutical Services Provider Agreement update #4

  • May 2018 - Alberta Blue Cross® Pharmaceutical Services Provider Agreement update #3

  • April 2018 - Take Home Naloxone (THN) Program Update

  • April 2018 - Alberta Blue Cross® Pharmaceutical Services Provider Agreement update #2

  • April 2018 - Alberta Blue Cross® Pharmaceutical Services Provider Agreement update #1

  • February 2018 - Pan-Canadian Competitive Value Price Initiative for Generic Drugs

  • February 2018 - Special Announcement: Pharmaceutical Services Provider Agreement

  • February 2018 - Pan-Canadian Pharmaceutical Alliance